Item 9 Labs Corp (INLB) Stock Price, Trades & News

Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The company also offers a dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. It also brings industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.

Financial Strength

	Name	Current	Vs Industry		Vs History

Growth Rank

	Name	Current	Vs Industry		Vs History

Momentum Rank

	Name	Current	Vs Industry		Vs History

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History

Profitability Rank

	Name	Current	Vs Industry		Vs History
	FCF Margin %	-13.19
	OCF Margin %	-5.69

GF Value Rank

2/10

	Name	Current	Vs Industry		Vs History

GF Value™

INLB

Warning Signs

Warning! GuruFocus detected issues with INLB. Try a 7-Day Free Trial to check it out.

Item 9 Labs Corp Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Item 9 Labs Corp Stock Events

Financials Calendars

Event	Date	Price ($)
Third quarter earnings results for 2026	2026-08-17	In 51 days
Second quarter earnings results for 2026	2026-07-03	In 6 days
First quarter earnings results for 2026	2026-06-30	In 3 days
Annual report for 2025	2026-06-29	In 2 days
General meeting for 2025	2026-06-29	In 2 days
0.05:1 Stock Split	2018-10-18	2.50 (+0.00%)
3:1 Stock Split	2012-01-03	--

Show

Entries

Guru Commentaries on OTCPK:INLB

No articles.

Press Release

	Subject	Date
	Item 9 Labs Corp. Retains Sharp Capital Advisors to Facilitate a Sale of the Business	2023-12-19
	Item 9 Labs Closes Out 2022 as a Top 10 Cannabis Brand in Arizona	2023-01-12
	Item 9 Labs Corp.'s Dispensary Brand Strengthens East Coast Footprint with First New Jersey Shop	2022-12-16
	Item 9 Labs Corp. Streamlines Operations and Strengthens Corporate Team Ahead of International Expansion	2022-12-08
	Item 9 Labs Corp. Appoints Mike Weinberger to CEO Ahead of Approaching Transformational Acquisition	2022-11-30
	Item 9 Labs Surpasses 30 Podium Placements With 2022 Fall Errl Cup Wins	2022-11-03
	Item 9 Labs Corp. Accelerates Growth of Unity Rd. Dispensary Franchise	2022-08-18
	Item 9 Labs Corp. to Host Third Quarter Fiscal Year 2022 Earnings Call on August 16 at 8:30 a.m. ET	2022-08-03
	Unity Rd. Opens First Medical Cannabis Establishment in South Dakota	2022-07-26
	Item 9 Labs Corp. Signs Definitive Agreement to Acquire Sessions Cannabis, One of Canada's Largest Cannabis Retail Franchisors	2022-07-14

10/Page

Articles on Item 9 Labs Corp

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.